Virology and molecular pathogenesis of HPV (human papillomavirus)- associated oropharyngeal squamous cell carcinoma

Biochemical Journal

Volumn 443, Issue 2, 2012, Pages 339-353

  Miller, Daniel L ^a   Puricelli, Michael D ^a   Stack, M Sharon ^b  

^a University of Missouri   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

Cancer; Head and neck squamous cell carcinoma (HNSCC); Human papillomavirus (HPV); Oropharyngeal squamous cell carcinoma (OPSCC)

Indexed keywords

APOLIPOPROTEIN E5; B LYMPHOCYTE ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN E1; GLYCOPROTEIN E2; INTERLEUKIN 1; MESSENGER RNA; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN E6; PROTEIN E7; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; WART VIRUS VACCINE;

CANCER PATIENT; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME ABERRATION; DISEASE ASSOCIATION; DNA REPAIR; DNA VIRUS; GENE EXPRESSION; GENOMIC INSTABILITY; HEAD AND NECK CARCINOMA; HUMAN; IMMUNE RESPONSE; KERATINOCYTE; MOLECULAR PATHOLOGY; MORTALITY; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TONSIL; TRANSCRIPTION REGULATION; VIROLOGY; VIRUS ENTRY; VIRUS GENE; VIRUS REPLICATION; WART VIRUS;

ANIMALS; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HUMANS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS;

HUMAN PAPILLOMAVIRUS;

EID: 84859471480     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20112017     Document Type: Review

References (147)

1. Duvvuri, U. and Myers, J. N. (2009) Cancer of the head and neck is the sixth most common cancer worldwide. Curr. Probl. Surg. 46, 114-117
2. Chaturvedi, A. K., Engels, E. A., Anderson, W. F. and Gillison, M. L. (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J. Clin. Oncol. 26, 612-619 (Pubitemid 351264356)
3. Wilczynski, S. P., Lin, B. T., Xie, Y. and Paz, I. B. (1998) Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distinct morphological patterns of tonsillar squamous cell carcinoma. Am. J. Pathol. 152, 145-156 (Pubitemid 28028055)
4. Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W. et al. (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 29, 4294-4301
5. Pannone, G., Santoro, A., Papagerakis, S., Lo Muzio, L., De Rosa, G. and Bufo, P. (2011) The role of human papillomavirus in the pathogenesis of head and neck squamous cell carcinoma: an overview. Infect. Agents Cancer 6, 4
6. Strati, K. and Lambert, P. F. (2008) Human Papillomavirus association with head and neck cancers: understanding virus biology and using it in the development of cancer diagnostics. Expert Opin. Med. Diagn. 2, 11-20
7. Petersen, P. E. (2009) Oral cancer prevention and control: the approach of the World Health Organization. Oral Oncol. 45, 454-460
8. Syrjänen, S. (2010) The role of human papillomavirus infection in head and neck cancers. Ann. Oncol. 21 (Suppl. 7), vii243-vii245
9. Dayyani, F., Etzel, C. J., Liu, M., Ho, C. H., Lippman, S. M. and Tsao, A. S. (2010) Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2, 15
10. Licitra, L., Zigon, G., Gatta, G., Sánchez, M. J. and Berrino, F. (2008) Human papillomavirus in HNSCC: a European epidemiologic perspective. Hematol. Oncol. Clin. North Am. 22, 1143-1153
11. Marur, S., D'Souza, G., Westra, W. H. and Forastiere, A. A. (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 11, 781-789
12. Snijders, P. J., Heideman, D. A. and Meijer, C. J. (2010) Methods for HPV detection in exfoliated cell and tissue specimens. APMIS 118, 520-528
13. Allen, C. T., Lewis, Jr, J. S., El-Mofty, S. K., Haughey, B. H. and Nussenbaum, B. (2010) Human papillomavirus and oropharynx cancer: biology, detection and clinical implications. Laryngoscope 120, 1756-1772
14. Syrjänen, S. (2005) Human papillomavirus (HPV) in head and neck cancer. J. Clin. Virol. 32, S59-S66
15. Gillison, M. L., Koch, W. M., Capone, R. B., Spafford, M., Westra, W. H., Wu, L., Zahurak, M. L., Daniel, R. W., Viglione, M., Symer, D. E. et al. (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92, 709-720 (Pubitemid 30365531)
16. Psyrri, A. and DiMaio, D. (2008) Human papillomavirus incervical and head-and-neck cancer. Nat. Clin. Pract. Oncol. 5, 24-31 (Pubitemid 351512426)
17. Melar-New, M. and Laimins, L. A. (2010) Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J. Virol. 10, 5212-5221
18. Moody, C. A. and Laimins, L. A. (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 10, 550-560
19. McCance, D. J. (2005) Human papillomaviruses and cell signaling. Sci. STKE 288, pe29
20. Kreimer, A. R., Clifford, G. M., Boyle, P. and Franceschi, S. (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev. 14, 467-475 (Pubitemid 40270113)
21. Gillison, M. L. and Lowy, D. R. (2004) A causal role for human papillomavirus in head and neck cancer. Lancet 363, 1488-1489
22. Kahn, T., Turazza, E., Ojeda, R., Bercovich, A., Stremlau, A., Lichter, P., Poustka, A., Grinstein, S. and zur Hausen, H. (1994) Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of the genomic target region. Cancer Res. 54, 1305-1312 (Pubitemid 24108073)
23. Shin, K. H., Min, B. M., Cherrick, H. M. and Park, N. H. (1994) Combined effects of human papillomavirus-18 and N-methyl-N′-nitro- N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol. Carcinog. 2, 76-86 (Pubitemid 24099078)
24. Joo, Y. H., Jung, C. K., Sun, D. I., Park, J. O., Cho, K. J. and Kim, M. S. (2012) High-risk human papillomavirus and cervical lymph node metastasis in patients with oropharyngeal cancer. Head Neck 34, 10-14
25. Schlecht, N. F., Burk, R. D., Adrien, L., Dunne, A., Kawachi, N., Sarta, C., Chen, Q., Brandwein-Gensler, M., Prystowsky, M. B., Childs, G. et al. (2007) Gene expression profiles in HPV-infected head and neck cancer. J. Pathol. 213, 283-293 (Pubitemid 350074018)
26. Brandwein-Gensler, M. and Smith, R. V. (2010) Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system. Head Neck Pathol. 4, 53-61
27. Chernock, R. D., El-Mofty, S. K., Thorstad, W. L., Parvin, C. A. and Lewis, Jr, J. S. (2009) HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol. 3, 186-194
28. El-Mofty, S. K. and Patil, S. (2006) Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101, 339-345 (Pubitemid 43303813)
29. Lee, W. T., Tubbs, R. R., Teker, A. M., Scharpf, J, Strome, M., Wood, B., Lorenz, R. R. and Hunt, J. (2008) Use of in situ hybridization to detect human papillomavirus in head and neck squamous cell carcinoma patients without a history of alcohol or tobacco use. Arch. Pathol. Lab. Med. 132, 1653-1656
30. Wentzensen, N., Wilson, L. E., Wheeler, C. M., Carreon, J. D., Gravitt, P. E., Schiffman, M. and Castle, P. E. (2010) Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study. Cancer Res. 70, 8578-8586
31. Häfner, N., Driesch, C., Gajda, M., Jansen, L., Kirchmayr, R., Runnebaum, I. B. and Dürst, M. (2008) Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 27, 1610-1617
32. Ragin, C. C. and Taioli, E. (2007) Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int. J. Cancer 121, 1813-1820 (Pubitemid 47417302)
33. Singhi, A. D. and Westra, W. H. (2010) Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer 116, 2166-2173
34. Smeets, S. J., Hesselink, A. T., Speel, E. J., Haesevoets, A., Snijders, P. J., Pawlita, M., Meijer, C. J., Braakhuis, B. J., Leemans, C. R. and Brakenhoff, R. H. (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int. J. Cancer 121, 2465-2472 (Pubitemid 350022416)
35. Klingenberg, B., Hafkamp, H. C., Haesevoets, A., Manni, J. J., Slootweg, P. J., Weissenborn, S. J., Klussman, J. P. and Speel, E. J. (2010) p16 INK4A overexpression isfrequently detected in tumour-free tonsil tissue without association with HPV. Histopathology 56, 957-967
36. Agoston, E. S., Robinson, S. J., Mehra, K. K., Birch, C., Semmel, D., Mirkovic, J., Haddad, R. I., Posner, M. R., Kindelberger, D., Krane, J. F. et al. (2010) Polymerase chain reaction detection of HPV in squamous carcinoma of the oropharynx. Am. J. Clin. Pathol. 134, 36-41
37. Kreimer, A. R., Clifford, G. M., Boyle, P. and Franceschi, S. (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systemic review. Cancer Epidemiol. Biomarkers Prev. 14, 467-475 (Pubitemid 40270113)
38. Longworth, M. S. and Laimins, L. A. (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68, 362-372 (Pubitemid 38756870)
39. Bienkowska-Haba, M. and Sapp, M. (2011) The cytoskeleton in papillomavirus infection. Viruses 3, 260-271
40. Horvath, C. A., Boulet, G. A., Renoux, V. M., Delvenne, P. O. and Bogers, J. P. (2010) Mechanisms of cell entry by human papillomaviruses: an overview. Virol. J. 7, 11
41. Letian, T. and Tianyu, Z. (2010) Cellular receptor binding and entry of human papillomavirus. Virol. J. 7, 2
42. Bretscher, M. S. (1992) Circulating integrins: α5β1, α6β4 and Mac-1, but not α3β1, α4β1 or LFA-1. EMBO J. 11, 405-410
43. Kurpakus, M. A., Quaranta, V. and Jones, J. C. (1991) Surface relocation of α6β4 integrins and assembly of hemidesmosomes in an in vitromodel of wound healing. J. Cell Biol. 115, 1737-1750 (Pubitemid 21910013)
44. Spoden, G., Freitag, K., Husmann, M., Boller, K., Sapp, M., Lambert, C. and Florin, L. (2008) Clathrin- and caveolin-independent entry of human papillomavirus type 16: involvement of tetraspanin-enriched microdomains (TEMs). PLoS ONE 3, e3313
45. Schneider, M. A., Spoden, G. A., Florin, L. and Lambert, C. (2011) Identification of the dynein light chains required for human papillomavirus infection. Cell. Microbiol. 13, 32-46
46. Kyo, S., Inoue, M., Hayasaka, N., Inoue, T., Yutsudo, M., Tanizawa, O. and Hakura, A. (1994) Regulation of early gene expression of human papillomavirus type 16 by inflammatory cytokines. Virology 200, 130-139 (Pubitemid 24170463)
47. Boccardo, E., Manzini Baldi, C. V., Carvalho, A. F., Rabachini, T., Torres, C., Barreta, L. A., Brentani, H. and Villa, L. L. (2010) Expression of human papillomavirus type 16 E7 oncoprotein alters keratinocytes expression profile in response to tumor necrosis factor-α. Carcinogenesis 31, 521-531
48. Boccardo, E., Lepique, A. P. and Villa, L. L. (2010) The role of inflammation in HPV carcinogenesis. Carcinogenesis 31, 1905-1912
49. Um, S. J., Rhyu, J. W., Kim, E. J., Jeon, K. C., Hwang, E. S. and Park, J. S. (2002) Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. Cancer Lett. 179, 205-212
50. Stanley, M. (2006) Immune response to human papillomavirus. Vaccine 24, S16-S22
51. Albers, A., Abe, K., Hunt, J., Wang, J., Lopez-Albaitero, A., Schaefer, C., Gooding, W., Whiteside, T. L., Ferrone, S., DeLeo, A. and Ferris, R. L. (2005) Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Cancer Res. 65, 11146-11155 (Pubitemid 41713386)
52. Hoffmann, T. K., Arsov, C., Schirlau, K., Bas, M., Friebe-Hoffmann, U., Klussmann, J. P., Scheckenbach, K., Balz, V., Bier, H. and Whiteside, T. L. (2006) T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx. Int. J. Cancer 118, 1984-1991
53. Park, J. S., Kim, E. J., Kwon, H. J., Hwang, E. S., Namkoong, S. E. and Um, S. J. (2000) Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein: implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J. Biol. Chem. 275, 6764-6769
54. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Snijders, P. J., Peto, J., Meijer, C. J. and Muñoz, N. (1999) Human papillomavirus is anecessary cause of invasive cervical cancer worldwide. J. Pathol. 189, 12-19 (Pubitemid 29406813)
55. Van Tine, B. A., Dao, L. D., Wu, S. Y., Sonbuchner, T. M., Lin, B. Y., Zou, N., Chiang, C. M., Broker, T. R. and Chow, L. T. (2004) Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc. Natl. Acad. Sci. U.S.A. 101, 4030-4035 (Pubitemid 38405878)
56. Williams, R., Lee, D. W., Elzey, B. D., Anderson, M. E., Hostager, B. S. and Lee, J. H. (2009) Preclinical models of HPV+ and HPV- HNSCC in mice: an immune clearance of HPV+ HNSCC. Head Neck 31, 911-918
57. Syrjänen, S. (2004) HPV infections and tonsillar carcinoma. J. Clin. Pathol. 57, 449-455
58. Kim, S. H., Juhn, Y. S., Kang, S., Park, S. W., Sung, M. W., Bang, Y. J. and Song, Y. S. (2006) Human papillomavirus 16E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt. Cell. Mol. Life Sci. 63, 930-938 (Pubitemid 43724080)
59. Kim, S. H., Koo, B. S., Kang, S., Park, K., Kim, H., Lee, K. R., Lee, M. J., Kim, J. M., Choi, E. C. and Cho, N. H. (2007) HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int. J. Cancer 120, 1418-1425 (Pubitemid 46355375)
60. Avery, J. K., Steele, P. F. and Avery, N. (2002) Oral Development and Histology, 3rd edn, Thieme, Stuttgart
61. Perry, M. E. (1994) The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J. Anat. 185, 111-127
62. Pai, S. I. and Westra, W. H. (2009) Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment. Annu. Rev. Pathol. 4, 49-70
63. Côté-Martin, A., Moody, C., Fradet-Turcotte, A., D'Abramo, C. M., Lehoux, M., Joubert, S., Poirier, G. G., Coulombe, B., Laimins, L. A. and Archambault, J. (2008) Human papillomavirus E1helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes. J. Virol. 82, 1271-1283
64. Cheng, S., Schmidt-Grimminger, D. C., Murant, T., Broker, T. R. and Chow, L. T. (1995) Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 9, 2335-2349
65. Frattini, M. G. and Laimins, L. A. (1994) The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b. Virology 204, 799-804 (Pubitemid 24330886)
66. Frattini, M. G. and Laimins, L. A. (1994) Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc. Natl. Acad. Sci. U.S.A. 91, 12398-12402
67. Hughes, F. J. and Romanos, M. A. (1993) E1 protein of human papillomavirus is a DNA helicase/ATPase. Nucleic Acids Res. 21, 5817-5823 (Pubitemid 24023692)
68. Muller, F., Giroglou, T. and Sapp, M. (1997) Characterization of the DNA-binding activity of the E1 and E2 proteins and the E1/E2 complex of human papillomavirus type 33. J. Gen. Virol. 78, 911-915 (Pubitemid 27188629)
69. Seo, Y. S., Muller, F., Lusky, M. and Hurwitz, J. (1993) Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication. Proc. Natl. Acad. Sci. U.S.A. 90, 702-706 (Pubitemid 23028933)
70. Amin, A. A., Titolo, S., Pelletier, A., Fink, D., Cordingley, M. G. and Archambault, J. (2000) Identification of domains of the HPV11 E1 protein required for DNA replication in vitro. Virology 272, 137-150 (Pubitemid 30429437)
71. Conger, K. L., Liu, J. S., Kuo, S. R., Chow, L. T. and Wang, T. S. (1999) Human papillomavirus DNA replication: interactions between the viral E1 protein and two subunits of human DNA polymerase alpha/primate. J. Biol. Chem. 274, 2696-2705 (Pubitemid 29075349)
72. Masterson, P. J., Stanley, M. A., Lewis, A. P. and Romanos, M. A. (1998) A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase α-primase p68 subunit. J. Virol. 72, 7407-7419 (Pubitemid 28377872)
73. Ma, T., Zou, N., Lin, B. Y., Chow, L. T. and Harper, J. W. (1999) Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication. Proc. Natl. Acad. Sci. U.S.A. 96, 382-387 (Pubitemid 29061217)
74. Sim, J., Ozgur, S., Lin, B. Y., Yu, J. H., Broker, T. R., Chow, L. T. and Griffith, J. (2007) Remodeling of the human papillomavirus type 11 replication origin into discrete nucleoprotein particles and looped structures by the E2 protein. J. Mol. Biol. 375, 1165-1177 (Pubitemid 50007844)
75. Chen, G. and Stenlund, A. (2000) Two patches of amino acids on the E2 DNA binding domain define the surface for interaction with E1. J. Virol. 74, 1506-1512 (Pubitemid 30044101)
76. Hegde, R. S., Grossman, S. R., Laimins, L. A. and Sigler, P. B. (1992) Crystal structure at1.7 Å of the bovine papillomavirus-1 E2 DNA-binding domain bound to its DNA target. Nature 359, 505-512
77. Harris, S. F. and Botchan, M. R. (1999) Crystal structure of the human papillomavirus type 18 E2 activation domain. Science 284, 1673-1677 (Pubitemid 29291378)
78. Demeret, C., Desaintes, C., Yaniv, M. and Thierry, F. (1997) Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes. J. Virol. 71, 9343-9349 (Pubitemid 27492376)
79. Dostatni, N., Lambert, P. F., Sousa, R., Ham, J., Howley, P. M. and Yaniv, M. (1991) The functional BPV-1 E2trans-activating protein can act as a repressor by preventing formation of the initiation complex. Genes Dev. 5, 1657-1671 (Pubitemid 21906070)
80. Steger, G. and Corbach, S. (1997) Dose-dependent regulation of the early promoter of HPV 18 by the viral E2 protein. J. Virol. 71, 50-58 (Pubitemid 26412264)
81. Schweiger, M. R., Ottinger, M., You, J. and Howley, P. M. (2007) Brd4-independent transcriptional repression function of the papillomavirus E2 proteins. J. Virol. 81, 9612-9622 (Pubitemid 350067667)
82. Smith, J. A., White, E. A., Sowa, M. E., Powell, M. L., Ottinger, M., Harper, J. W. and Howley, P. M. (2010) Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc. Natl. Acad. Sci. U.S.A. 107, 3752-3757
83. Mole, S., Veerapraditsin, T., McPhillips, M. G. and Graham, S. V. (2006) Regulation of splicing-associated SR proteins by HPV-16. Biochem. Soc. Trans. 34, 1145-1147
84. McFarlane, M. and Graham, S. V. (2010) Human papillomavirus regulation of SR proteins. Biochem. Soc. Trans. 38, 1116-1121
85. Xue, Y., Bellanger, S., Zhang, W., Lim, D., Low, J., Lunny, D. and Thierry, F. (2010) HPV16 E2is an immediate early marker of viral infection, preceding E7 expression in precursor structures of cervical carcinoma. Cancer Res. 70, 5316-5325
86. Wu, M. H., Chan, J. Y., Liu, P. Y., Liu, S. T. and Huang, S. M. (2007) Human papillomavirus E2protein associates with nuclear receptors to stimulate nuclear receptor- and E2-dependent transcriptional activations in human cervical carcinoma cells. Int. J. Biochem. Cell Biol. 39, 413-425 (Pubitemid 44855660)
87. Remm, M., Remm, A. and Ustav, M. (1999) Human papillomavirus type 18E1 protein is translated from polycistronic mRNA by a discontinuous scanning mechanism. J. Virol. 73, 3062-3070 (Pubitemid 29135695)
88. Knight, G. L., Pugh, A. G., Yates, E., Bell, I., Wilson, R., Moody, C. A., Laimins, L. A. and Roberts, S. (2011) A cyclin-binding motif in human papillomavirus type 18 (HPV18) E1∧E4 is necessary for association with CDK-cyclin complexes and G2/M cell cycle arrest of keratinocytes, but is not required for differentiation-dependent viral genome amplification or L1 capsid protein expression. Virology 412, 196-210
89. McIntosh, P. B., Laskey, P., Sullivan, K., Davy, C., Wang, Q., Jackson, D. J., Griffin, H. M. and Doorbar, J. (2010) E1-E4-mediated keratin phosphorylation and ubiquitylation: a mechanism for keratin depletion in HPV16-infected epithelium. J. Cell Sci. 123, 2810-2822
90. Wilson, R., Ryan, G. B., Knight, G. L., Laimins, L. A. and Roberts, S. (2007) The full-length E1E4 protein of human papillomavirus type 18 modulates differentiation-dependent viral DNA amplification and late gene expression. Virology 362, 453-460 (Pubitemid 46678156)
91. Pim, D., Collins, M. and Banks, L. (1992) Human papillomavirus type 16E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 7, 27-32
92. Tsai, T. C. and Chen, S. L. (2003) The biochemical and biological functions of human papillomavirus type 16 E5 protein. Arch. Virol. 148, 1445-1453
93. Fehrmann, F., Klumpp, D. J. and Laimins, L. A. (2003) Human papillomavirus type 31E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation. J. Virol. 77, 2819-2831 (Pubitemid 36228065)
94. Alazawi, W., Pett, M., Strauss, S., Moseley, R., Gray, J., Stanley, M. and Coleman, N. (2004) Genomic imbalances in70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome. Br. J. Cancer 91, 2063-2070 (Pubitemid 40128773)
95. Jeon, S., Allen-Hoffmann, B. L. and Lambert, P. F. (1995) Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69, 2989-2997
96. Dahlgren, L., Mellin, H., Wangsa, D., Heselmeyer-Haddad, K., Björnestål, L., Lindholm, J., Munck-Wikland, E., Auer, G., Ried, T. and Dalianis, T. (2003) Comparative genomic hybridization analysis of tonsillar cancer reveals a different pattern of genomic imbalances in human papillomavirus-positive and -negative tumors. Int. J. Cancer 107, 244-249 (Pubitemid 37152904)
97. Jung, A. C., Briolat, J., Millon, R., de Reynìes, A., Rickman, D., Thomas, E., Abecassis, J., Clavel, C. and Wasylyk, B. (2010) Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int. J. Cancer 126, 1882-1894
98. Duensing, A., Spardy, N., Chatterjee, P., Zheng, L., Parry, J., Cuevas, R., Korzeniewski, N. and Duensing, S. (2009) Centrosome overduplication, chromosomal instability, and human papillomavirus oncoproteins. Environ. Mol. Mutagen 50, 741-747
99. DeFilippis, R. A., Goodwin, E. C., Wu, L. and DiMaio, D. (2003) Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J. Virol. 77, 1551-1563 (Pubitemid 36055574)
100. Wang, H. K., Duffy, A. A., Broker, T. R. and Chow, L. T. (2009) Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 23, 181-194
101. McCance, D. J., Kopan, R., Fuchs, E. and Laimins, L. A. (1988) Human papillomavirus type 16alters human epithelial cell differentiation in vitro. Proc. Natl. Acad. Sci. U.S.A. 85, 7169-7173
102. Duensing, S. and Münger, K. (2002) Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene 21, 6241-6248
103. Bedard, K. M., Underbrink, M. P., Howie, H. L. and Galloway, D. A. (2008) The E6oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J. Virol. 82, 3894-3902 (Pubitemid 351521226)
104. Huibregtse, J. M., Scheffner, M. and Howley, P. M. (1991) A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10, 4129-4135 (Pubitemid 21905444)
105. Brimer, N., Lyons, C. and Vande Pol, SB. (2007) Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein. Virology 358, 303-310 (Pubitemid 46136426)
106. Lechner, M. S. and Laimins, L. A. (1994) Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J. Virol. 68, 4262-4273 (Pubitemid 24183019)
107. Muench, P., Probst, S., Schuetz, J., Leiprecht, N., Busch, M., Wesselborg, S., Stubenrauch, F. and Iftner, T. (2010) Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis. Cancer Res. 70, 6913-6924
108. Kumar, A., Zhao, Y., Meng, G., Zeng, M., Srinivasan, S., Delmolino, L. M., Gao, Q., Dimri, G., Weber, G. F., Wazer, D. E. et al. (2002) Human papillomavirus oncoprotein E6inactivates the transcriptional coactivator human ADA3. Mol. Cell. Biol. 22, 5801-5812 (Pubitemid 34815829)
109. Patel, D., Huang, S. M., Baglia, L. A. and McCance, D. J. (1999) The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 18, 5061-5072 (Pubitemid 29443808)
110. Shamanin, V. A. and Androphy, E. J. (2004) Immortalization of human mammary epithelial cells is associated with inactivation of the p14ARF-p53 pathway. Mol. Cell. Biol. 24, 2144-2152 (Pubitemid 38248952)
111. Shamanin, V. A., Sekaric, P. and Androphy, E. J. (2008) hAda3 degradation by papillomavirus type 16 E6 correlates with abrogation of the p14ARF-p53 pathway and efficient immortalization of human mammary epithelial cells. J. Virol. 82, 3912-3920 (Pubitemid 351521228)
112. Klingelhutz, A. J., Foster, S. A. and McDougall, J. K. (1996) Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79-82 (Pubitemid 26076241)
113. Wise-Draper, T. M. and Wells, S. I. (2008) Papillomavirus E6 and E7 proteins and their cellular targets. Front. Biosci. 13, 1003-1017 (Pubitemid 351594744)
114. Howie, H. L., Katzenellenbogen, R. A. and Galloway, D. A. (2009) Papillomavirus E6 proteins. Virology 384, 324-334
115. Liu, Y., Cherry, J. J., Dineen, J. V., Androphy, E. J. and Baleja, J. D. (2009) Determinants of stability for the E6 protein of papillomavirus type 16. J. Mol. Biol. 386, 1123-1137
116. Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A. and Klingelhutz, A. J. (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88 (Pubitemid 28520454)
117. Nguyen, M. L., Nguyen, M. M., Lee, D., Griep, A. E. and Lambert, P. F. (2003) The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J. Virol. 77, 6957-6964 (Pubitemid 36666888)
118. Sherr, C. J. and McCormick, F. (2002) The RB and p53 pathways in cancer. Cancer Cell 2, 103-112
119. Dreier, K., Scheiden, R., Lener, B., Ehehalt, D., Pircher, H., Müller-Holzner, E., Rostek, U., Kaiser, A., Fiedler, M., Ressler, S. et al. (2011) Subcellular localization of the human papillomavirus 16 E7 oncoprotein in CaSki cells and its detection in cervical adenocarcinoma and adenocarcinoma in situ. Virology 409, 54-68
120. Melar-New, M. and Laimins, L. A. (2010) Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J. Virol. 84, 5212-5221
121. Wang, X., Tang, S., Le, S. Y., Lu, R., Rader, J. S., Meyers, C. and Zheng, Z. M. (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS ONE 3, e2557
122. Wang, X., Wang, H. K., McCoy, J. P., Banerjee, N. S., Rader, J. S., Broker, T. R., Meyers, C., Chow, L. T. and Zheng, Z. M. (2009) Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 15, 637-647
123. Martinez, I., Gardiner, A. S., Board, K. F., Monzon, F. A., Edwards, R. P. and Khan, S. A. (2008) Human papillomavirus type 16reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27, 2575-2582 (Pubitemid 351550884)
124. Greco, D., Kivi, N., Qian, K, Leivonen, S. K., Auvinen, P. and Auvinen, E. (2011) Human papillomavirus 16E5 modulates the expression of host microRNAs. PLoS ONE 6, e21646
125. Wang, X., Meyers, C., Guo, M. and Zheng, Z. M. (2010) Up-regulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR34a pathway. Int. J. Cancer 129, 1362-1372
126. Zheng, Z. M. and Wang, X. (2011) Regulation of cellular miRNA expression by human papillomaviruses. Biochim. Biophys. Acta 1809, 668-677
127. Pyeon, D., Newton, M. A., Lambert, P. F., den Boon, J. A., Sengupta, S., Marsit, C. J., Woodworth, C. D., Connor, J. P., Haugen, T. H., Smith, E. M. et al. (2007) Fundamental differences incell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 67, 4605-4619 (Pubitemid 46910165)
128. Lohavanichbutr, P., Houck, J., Fan, W., Yueh, B., Mendez, E., Futran, N., Doody, D. R., Upton, M. P., Farwell, D. G., Schwartz, S. M. et al. (2009) Genomewide gene expression profiles of HPV-positive and HPV-negative oropharyngeal cancer: potential implications for treatment choices. Arch. Otolaryngol. Head Neck Surg. 135, 180-188
129. Wilting, S. M., Smeets, S. J., Snijders, P. J., van Wieringen, W. N., van de Wiel, M. A., Meijer, G. A., Ylstra, B., Leemans, C. R., Meijer, C. J., Brakenhoff, R. H. et al. (2009) Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck. BMC Med. Genomics 2, 32
130. Martinez, I., Wang, J., Hobson, K. F., Ferris, R. L. and Khan, S. A. (2007) Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur. J. Cancer 43, 415-432 (Pubitemid 46123982)
131. Schlecht, N. F., Burk, R. D., Adrien, L., Dunne, A., Kawachi, N., Sarta, C., Chen, Q., Brandwein-Gensler, M., Prystowsky, M. B., Childs, G. et al. (2007) Gene expression profiles in HPV-infected head and neck cancer. J. Pathol. 213, 283-293 (Pubitemid 350074018)
132. Klussmann, J. P., Mooren, J. J., Lehnen, M., Claessen, S. M., Stenner, M., Huebbers, C. U., Weissenborn, S. J., Wedemeyer, I., Preuss, S. F., Straetmans, J. M. et al. (2009) Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin. Cancer Res. 15, 1779-1786
133. Smith, E. M., Ritchie, J. M., Summersgill, K. F., Hoffman, H. T., Wang, D. H., Haugen, T. H. and Turek, L. P. (2004) Human papillomavirus inoral exfoliated cells and risk of head and neck cancer. J. Natl. Cancer Inst. 96, 449-455 (Pubitemid 38443648)
134. D'Souza, G., Kreimer, A. R., Viscidi, R., Pawlita, M., Fakhry, C., Koch, W. M., Westra, W. H. and Gillison, M. L. (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356, 1944-1956 (Pubitemid 46740304)
135. D'Souza, G., Agrawal, Y., Halpern, J., Bodison, S. and Gillison, M. L. (2009) Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J. Infect. Dis. 199, 1263-1269
136. Hansson, B. G., Rosenquist, K., Antonsson, A., Wennerberg, J., Schildt, E. B., Bladström, A. and Andersson, G. (2005) Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol. 125, 1337-1344 (Pubitemid 41722001)
137. Clifford, G. M., Gallus, S., Herrero, R., Muñoz, N., Snijders, P. J., Vaccarella, S., Anh, P. T., Ferreccio, C., Hieu, N. T., Matos, E. et al. (2005) Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366, 991-998 (Pubitemid 41323035)
138. de Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N. and Bosch, F. X. (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect. Dis. 7, 453-459 (Pubitemid 46962343)
139. Fakhry, C., Westra, W. H., Li, S., Cmelak, A., Ridge, J. A., Pinto, H., Forastiere, A. and Gillison, M. L. (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl. Cancer Inst. 100, 261-269 (Pubitemid 351480538)
140. D'Souza, G., Sugar, E., Ruby, W., Gravitt, P. and Gillison, M. L. (2005) Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR. J. Clin. Microbiol. 43, 5526-5535 (Pubitemid 41612325)
141. Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I.,
142. Fischer, C. A., Kampmann, M., Zlobec, I., Green, E., Tornillo, L., Lugli, A., Wolfensberger, M. and Terracciano, L. M. (2010) p16 expression inoropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann. Oncol. 10, 1961-1966
143. Chen, R., Sehr, P., Waterboer, T., Leivo, I., Pawlita, M., Vaheri, A. and Aaltonen, L. M. (2005) Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue. J. Clin. Microbiol. 43, 1408-1410 (Pubitemid 40364973)
144. Chaturvedi, A. K., Engels, E. A., Anderson, W. F. and Gillison, M. L. (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J. Clin. Oncol. 26, 612-619 (Pubitemid 351264356)
145. Settle, K., Posner, M. R., Schumaker, L. M., Tan, M., Suntharalingam, M., Goloubeva, O., Strome, S. E., Haddad, R. I., Patel, S. S., Cambell, 3rd, E. V. et al. (2009) Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev. Res. 2, 776-781
146. Chen, L. M., Li, G., Reitzel, L. R., Pytynia, K. B., Zafereo, M. E., Wei, Q. and Sturgis, E. M. (2009) Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev. Res. 2, 782-791
147. Schrank, T. P., Han, Y., Weiss, H. and Resto, V. A. (2011) Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States: possible role for human papillomavirus in survival disparities. Head Neck 33, 45-53